Delivery Order SPE2DB22D1103-SPE2DB25FTTD9
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $16,082.62 on May 27, 2025, for the supply of Kerendia 20 mg tablets (30-count packages). This firm fixed-price delivery order, with an ultimate completion date of May 28, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,746.44 to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (90-count units) under a firm fixed-price contract. The delivery order was competitively awarded without set-aside designation on July 15, 2025, with an ultimate completion date of July 16, 2025. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete...
- The Defense Logistics Agency awarded a delivery order valued at $14,416.67 to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (quantity: 30 count) with an ultimate completion date of August 20, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, awarded competitively on August 19, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $38,149.93 to supply Kerendia 10 mg tablets (30-count units) with a firm fixed price structure. This competitive award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract does not utilize a set-aside designation and will be performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Kerendia 10 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, valued at $6,857.16, was competitively awarded with no set-aside designation and is scheduled for completion by August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count supply) under a firm fixed-price contract valued at $1,492.08, with an ultimate completion date of September 16, 2025. This competitively awarded, non-set-aside delivery order was executed on September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,737.75 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (90-count supply) on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Kerendia 20 mg tablets (30-count) with a ceiling value of $3,084.90 under a firm fixed-price contract. This delivery order was competitively awarded with no set-aside designation and is scheduled for completion by August 26, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,568.65 to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (30-count units), with an ultimate completion date of August 13, 2025. The contract was competitively awarded with no set-aside designation and employs firm fixed-price pricing. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location and will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 17, 2025, for the supply of Kerendia 20 mg tablets (30-count units) valued at $2,799.21. This firm fixed-price delivery order, with an ultimate completion date of May 19, 2025, represents a non-competitive, non-set-aside award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The product will be delivered to the same location, supporting the federal government's...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FTTD9Delivery Order
The Defense Logistics Agency awarded a $7,668.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (90-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement executed under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor contract running through December 2026 that serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains through this flexible contract mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 7/31/25 |